BGLC
BioNexus Gene Lab Corp.
NASDAQ · Healthcare · Medical - Diagnostics & Research · MY
$0.92
−6.38%Forward multiples
Based on analyst estimates
- P/E forward
- —
- P/E 2026E
- —
- P/E 2027E
- —
- P/E 2028E
- —
- P/S forward
- —
Trailing multiples
Trailing twelve months
- P/E TTM
- —
- PEG TTM
- —
- Price / book
- 0.35x
- Price / sales
- 0.86x
- Price / cash flow
- -3.20x
Enterprise value
- Enterprise value
- -$631.5K
- EV / sales
- -0.20x
- EV / EBITDA
- 0.26x
- EV / EBIT
- 0.24x
- Market cap
- $2.7M
Trailing, forward and enterprise-value multiples for the requested listing · Data as of Jun 1, 2026